13F Pro

SEC Form 4 reporting owner

Saunders Brent L

Saunders Brent L has filed 9 Form 4 transactions reported between February 23, 2026 and August 5, 2026, as Chairman of the Board and CEO, CEO and Chairman of the Board of Bausch & Lomb Corp and a reporting owner of ARS Pharmaceuticals, Inc..

Name as filed: SAUNDERS BRENT L

Open-market buys, 24 mo
$252K
1 lines
Open-market sales, 24 mo
None
reported
Companies
2
with Form 4 filings
Latest transaction
Aug 5, 2026
transaction date

Roles and reported holdings

  • BLCOBausch & Lomb Corp
    Feb 23, 2026 – Aug 5, 2026

    Chairman of the Board and CEO, CEO and Chairman of the Board

    Held directly974,158 sh as of Aug 5, 2026 · Form 4

    24 months: $252K bought

  • SPRYARS Pharmaceuticals, Inc.
    Jun 24, 2026

    Reporting owner

    No common-stock holding reported on a purchase, sale, gift or withholding line.

Transaction history

All 9 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Aug 5, 2026BLCOChairman of the Board and CEOGrant or awardCode A · direct281,879—Form 4
Aug 5, 2026BLCOChairman of the Board and CEOShares withheld for tax or exercise priceCode F · direct4,231$71K@ $16.76Form 4
Jun 24, 2026SPRYGrant or awardCode A · direct30,000—Form 4
May 22, 2026BLCOChairman of the Board and CEOShares withheld for tax or exercise priceCode F · direct2,886$46K@ $15.92Form 4
Mar 6, 2026BLCOCEO and Chairman of the BoardOpen-market purchaseCode P · direct14,700$252K@ $17.14Form 4
Feb 27, 2026BLCOCEO and Chairman of the BoardShares withheld for tax or exercise priceCode F · direct24,649$451K@ $18.30Form 4
Feb 26, 2026BLCOCEO and Chairman of the BoardShares withheld for tax or exercise priceCode F · direct22,059$408K@ $18.49Form 4
Feb 25, 2026BLCOCEO and Chairman of the BoardGrant or awardCode A · direct327,102—Form 4
Feb 23, 2026BLCOCEO and Chairman of the BoardShares withheld for tax or exercise priceCode F · direct65,444$1.2M@ $17.99Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.